Yuliya Komarova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuliya Komarova has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Vladimirovich Zakharov
Samara Medical University, RUSSIA
13 shared publications - Igor V. Shirolapov
Samara State Medical University, Russia
13 shared publications - Natalia Romanchuk
Samara State Medical University, Russia
12 shared publications - Mariya Sergeeva
Samara State Medical University, Russia
11 shared publications - Elena Khivintseva
Samara State Medical University, Russia
6 shared publications - Alexander Vladimirovich Kolsanov
Samara State Medical University, Russia
3 shared publications
Latest Publications
- 28 December 2026
- Published by IGI Global Scientific Publishing
- p. 443-474
Scalable Lightweight AI-Enabled EEG Wearables for Ambulatory Epilepsy Diagnosis and Polysomnography
This chapter provides a systematic analysis of hardware platforms for scalable, lightweight artificial intelligence enabled electroencephalographic (EEG) wearables intended for long term ambulatory epilepsy diagnosis and polysomnography. The clinical need for multi day recordings outside hospital settings is first established, highlighting the limitations of routine inpatient EEG and the high prevalence of unreported seizures. The fundamental trade offs between channel count, battery life, and information content are examined, with power consumption identified as the dominant design constraint. Dry and textile electrode technologies are evaluated in terms of electrode skin impedance, motion artifact suppression, and long term stability. A comparative analysis of existing wearable EEG systems is presented, followed by clinical benefits, regulatory pathways, and current limitations. Future trends such as neuromorphic processors, energy harvesting, and hybrid biocompatible interfaces are discussed.
- 28 December 2026
- Published by IGI Global Scientific Publishing
- p. 443-474
Scalable Lightweight AI-Enabled EEG Wearables for Ambulatory Epilepsy Diagnosis and Polysomnography
This chapter provides a systematic analysis of hardware platforms for scalable, lightweight artificial intelligence enabled electroencephalographic (EEG) wearables intended for long term ambulatory epilepsy diagnosis and polysomnography. The clinical need for multi day recordings outside hospital settings is first established, highlighting the limitations of routine inpatient EEG and the high prevalence of unreported seizures. The fundamental trade offs between channel count, battery life, and information content are examined, with power consumption identified as the dominant design constraint. Dry and textile electrode technologies are evaluated in terms of electrode skin impedance, motion artifact suppression, and long term stability. A comparative analysis of existing wearable EEG systems is presented, followed by clinical benefits, regulatory pathways, and current limitations. Future trends such as neuromorphic processors, energy harvesting, and hybrid biocompatible interfaces are discussed.
- 11 November 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 64 (9)
Adjunctive Multisensory Passive Immersive Virtual Reality With Synchronized Plantar Tactile Stimulation for Gait and Balance Disorders in Parkinson's Disease: An Exploratory Randomized Controlled Trial
Postural‐locomotor disorders, particularly freezing of gait and postural instability, are among the most disabling symptoms of advanced Parkinson's disease (PD) and respond only partially to dopaminergic therapy. Evidence for virtual reality (VR) approaches in moderate to severe PD remains limited. This prospective randomized controlled open‐label exploratory trial evaluated the addition of multisensory passive immersive VR with synchronized plantar tactile stimulation to conventional rehabilitation for gait, balance, and freezing disorders in moderate‐to‐severe PD (Hoehn and Yahr Stages 2–4). In the study, 80 PD patients were randomized into an experimental group (EXP, n = 40) receiving standard pharmacotherapy and conventional rehabilitation plus 10 sessions of passive immersive VR with synchronized plantar tactile stimulation and a comparison group (COM, n = 40) receiving standard pharmacotherapy and conventional rehabilitation only. Because the VR sessions were added to an otherwise identical program, the trial evaluates the effect of adding this intervention rather than a VR‐ or tactile‐specific effect. Outcomes were assessed at baseline and after 10 days using the Unified Parkinson's Disease Rating Scale (UPDRS), Berg Balance Scale (BBS), and Freezing of Gait Questionnaire (FoG‐Q). The EXP group showed significant improvements in the UPDRS “Gait” cluster (an eight‐item composite of UPDRS items 2.11, 2.12, 2.13, 3.9, 3.10, 3.11, 3.12, and 3.13, range 0–32; median from 12.5 to 8.0 points, p < 0.001), BBS (from 38.0 to 43.5 points, p < 0.001), and FoG‐Q (from 9.0 to 6.5 points, p < 0.001). A formal group × time analysis confirmed a differential treatment effect for every outcome. For the main outcome, the UPDRS “Gait” cluster, the baseline‐adjusted between‐group difference was −2.48 points (95% CI −3.37 to −1.59; p < 0.001; Hedges' g = 1.16). Large effects also favored the EXP group for the FoG‐Q (−2.14 points, 95% CI −2.62 to −1.66; g = 1.65), the BBS (+2.20 points, 95% CI 1.31 to 3.10; g = 1.06), the UPDRS freezing subscore (items 2.13 + 3.11; −0.89 points, 95% CI −1.13 to −0.66; g = 1.32), and the UPDRS postural subscore (items 3.12 + 3.13; −0.74 points, 95% CI −1.08 to −0.41; g = 0.93). Secondary outcome p ‐values were adjusted for multiple comparisons using the Holm and Benjamini–Hochberg procedures. By contrast, in the COM group, no significant change was observed for freezing of gait ( p = 0.083), and improvements in other outcomes were smaller than in the EXP group. No serious adverse events were recorded. The trial was exploratory, so the effect estimates require confirmation rather than supporting robustness in themselves. Overall, multisensory passive immersive VR with synchronized plantar tactile stimulation was well tolerated and shows preliminary promise as an adjunct to conventional rehabilitation for gait and balance disorders in moderate‐to‐severe PD. Wider clinical implementation requires long‐term multicenter studies with standardized assessment criteria and analysis of long‐term sustainability. These findings support integrating passive VR technologies into personalized neurorehabilitation programs.
- 11 November 2026
- Published by Wiley in European Journal of Neuroscience
- Vol. 64 (9)
Adjunctive Multisensory Passive Immersive Virtual Reality With Synchronized Plantar Tactile Stimulation for Gait and Balance Disorders in Parkinson's Disease: An Exploratory Randomized Controlled Trial
Postural‐locomotor disorders, particularly freezing of gait and postural instability, are among the most disabling symptoms of advanced Parkinson's disease (PD) and respond only partially to dopaminergic therapy. Evidence for virtual reality (VR) approaches in moderate to severe PD remains limited. This prospective randomized controlled open‐label exploratory trial evaluated the addition of multisensory passive immersive VR with synchronized plantar tactile stimulation to conventional rehabilitation for gait, balance, and freezing disorders in moderate‐to‐severe PD (Hoehn and Yahr Stages 2–4). In the study, 80 PD patients were randomized into an experimental group (EXP, n = 40) receiving standard pharmacotherapy and conventional rehabilitation plus 10 sessions of passive immersive VR with synchronized plantar tactile stimulation and a comparison group (COM, n = 40) receiving standard pharmacotherapy and conventional rehabilitation only. Because the VR sessions were added to an otherwise identical program, the trial evaluates the effect of adding this intervention rather than a VR‐ or tactile‐specific effect. Outcomes were assessed at baseline and after 10 days using the Unified Parkinson's Disease Rating Scale (UPDRS), Berg Balance Scale (BBS), and Freezing of Gait Questionnaire (FoG‐Q). The EXP group showed significant improvements in the UPDRS “Gait” cluster (an eight‐item composite of UPDRS items 2.11, 2.12, 2.13, 3.9, 3.10, 3.11, 3.12, and 3.13, range 0–32; median from 12.5 to 8.0 points, p < 0.001), BBS (from 38.0 to 43.5 points, p < 0.001), and FoG‐Q (from 9.0 to 6.5 points, p < 0.001). A formal group × time analysis confirmed a differential treatment effect for every outcome. For the main outcome, the UPDRS “Gait” cluster, the baseline‐adjusted between‐group difference was −2.48 points (95% CI −3.37 to −1.59; p < 0.001; Hedges' g = 1.16). Large effects also favored the EXP group for the FoG‐Q (−2.14 points, 95% CI −2.62 to −1.66; g = 1.65), the BBS (+2.20 points, 95% CI 1.31 to 3.10; g = 1.06), the UPDRS freezing subscore (items 2.13 + 3.11; −0.89 points, 95% CI −1.13 to −0.66; g = 1.32), and the UPDRS postural subscore (items 3.12 + 3.13; −0.74 points, 95% CI −1.08 to −0.41; g = 0.93). Secondary outcome p ‐values were adjusted for multiple comparisons using the Holm and Benjamini–Hochberg procedures. By contrast, in the COM group, no significant change was observed for freezing of gait ( p = 0.083), and improvements in other outcomes were smaller than in the EXP group. No serious adverse events were recorded. The trial was exploratory, so the effect estimates require confirmation rather than supporting robustness in themselves. Overall, multisensory passive immersive VR with synchronized plantar tactile stimulation was well tolerated and shows preliminary promise as an adjunct to conventional rehabilitation for gait and balance disorders in moderate‐to‐severe PD. Wider clinical implementation requires long‐term multicenter studies with standardized assessment criteria and analysis of long‐term sustainability. These findings support integrating passive VR technologies into personalized neurorehabilitation programs.
- Open Access
- 8 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (19) , 7754
Longitudinal Changes in the Digitized Archimedes Spiral Drawing Test Following iTBS of the Left DLPFC in Parkinson’s Disease: An Exploratory Feasibility Study
Background: The Digitized Archimedes Spiral Drawing Test (DAST) provides objective assessment of fine motor function, but its utility as a biomarker for neuromodulatory interventions in Parkinson’s disease (PD) remains underexplored. Objective: To explore longitudinal changes in a comprehensive set of DAST parameters following a course of intermittent theta-burst stimulation (iTBS) of the left dorsolateral prefrontal cortex (DLPFC) in PD patients as a feasibility study. Methods: Twenty-seven participants (17 PD patients, 10 healthy controls) underwent DAST testing at baseline and at 1.5 and 6 months; the immediate post-course assessment was performed only in the PD group, whereas the controls received a single sham session. Forty kinematic, temporal, spatial and tremor-related metrics were extracted. Clinical assessment was performed using MDS-UPDRS. Linear mixed models, ANCOVA, and Friedman tests were applied for statistical analysis. Results: Temporal and kinematic parameters showed modest changes over the study period, including mean velocity (p = 0.0437), trial duration (p = 0.0437), and mean number of movements (p = 0.0485). In contrast, spatial parameters (total error and length-normalized error) showed no significant change over the study period but maintained stable between-group differences across all stages (p = 0.0251 and p = 0.0123 at 6 months). Age and sex significantly influenced several DAST metrics: age affected mean error for spiral types 2, 3, and 4 (p = 0.008–0.047), while sex influenced dominant tremor frequency, tremor power ratio (p = 0.005–0.007), and mean error for spiral types 3 and 4 (p = 0.023–0.039). The DAST showed limited ability to differentiate adjacent PD stages: only mean velocity of spiral type 2 differed between Hoehn and Yahr stages 2 and 3 at baseline (p = 0.0176), with no significant differences between subgroups at 6 months. Conclusions: The changes over the study period were observed in kinematic and temporal DAST measures, but not in spatial parameters. These preliminary findings may suggest a possible dissociation between parameters predominantly reflecting motor planning and those reflecting trajectory execution. It may be tentatively hypothesized that DLPFC stimulation primarily modulates motor planning processes and movement execution strategies, whereas trajectory implementation and spatial coordination appear to be mediated by other cortico-subcortical structures. DAST shows potential as an objective tool for monitoring motor changes in PD; nevertheless, its responsiveness should be further evaluated in larger studies.
- 8 October 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (19) , 7754
Open AccessLongitudinal Changes in the Digitized Archimedes Spiral Drawing Test Following iTBS of the Left DLPFC in Parkinson’s Disease: An Exploratory Feasibility Study
Background: The Digitized Archimedes Spiral Drawing Test (DAST) provides objective assessment of fine motor function, but its utility as a biomarker for neuromodulatory interventions in Parkinson’s disease (PD) remains underexplored. Objective: To explore longitudinal changes in a comprehensive set of DAST parameters following a course of intermittent theta-burst stimulation (iTBS) of the left dorsolateral prefrontal cortex (DLPFC) in PD patients as a feasibility study. Methods: Twenty-seven participants (17 PD patients, 10 healthy controls) underwent DAST testing at baseline and at 1.5 and 6 months; the immediate post-course assessment was performed only in the PD group, whereas the controls received a single sham session. Forty kinematic, temporal, spatial and tremor-related metrics were extracted. Clinical assessment was performed using MDS-UPDRS. Linear mixed models, ANCOVA, and Friedman tests were applied for statistical analysis. Results: Temporal and kinematic parameters showed modest changes over the study period, including mean velocity (p = 0.0437), trial duration (p = 0.0437), and mean number of movements (p = 0.0485). In contrast, spatial parameters (total error and length-normalized error) showed no significant change over the study period but maintained stable between-group differences across all stages (p = 0.0251 and p = 0.0123 at 6 months). Age and sex significantly influenced several DAST metrics: age affected mean error for spiral types 2, 3, and 4 (p = 0.008–0.047), while sex influenced dominant tremor frequency, tremor power ratio (p = 0.005–0.007), and mean error for spiral types 3 and 4 (p = 0.023–0.039). The DAST showed limited ability to differentiate adjacent PD stages: only mean velocity of spiral type 2 differed between Hoehn and Yahr stages 2 and 3 at baseline (p = 0.0176), with no significant differences between subgroups at 6 months. Conclusions: The changes over the study period were observed in kinematic and temporal DAST measures, but not in spatial parameters. These preliminary findings may suggest a possible dissociation between parameters predominantly reflecting motor planning and those reflecting trajectory execution. It may be tentatively hypothesized that DLPFC stimulation primarily modulates motor planning processes and movement execution strategies, whereas trajectory implementation and spatial coordination appear to be mediated by other cortico-subcortical structures. DAST shows potential as an objective tool for monitoring motor changes in PD; nevertheless, its responsiveness should be further evaluated in larger studies.
- 7 August 2026
- Published by IGI Global Scientific Publishing
- p. 119-148
Integrating Brain-Computer Interfaces and Artificial Intelligence for Deep Interpretation of Cognitive States in Decision Support
The chapter establishes Hybrid Intelligence (HI) as a synergistic paradigm, integrating human cognition with artificial intelligence via adaptive Brain-Computer Interfaces (BCI). It addresses the persistent “cognitive gap” in decision support by detailing the core components—human cognitive states and enabling technologies like EEG and fNIRS—and their integration into a closed-loop architecture. The discussion focuses on creating a “deep interpretation” engine for real-time cognitive state decoding, explores applications in critical domains, and examines the ethical and practical challenges of deploying such systems to augment human decision-making effectively.
- 7 August 2026
- Published by IGI Global Scientific Publishing
- p. 119-148
Integrating Brain-Computer Interfaces and Artificial Intelligence for Deep Interpretation of Cognitive States in Decision Support
The chapter establishes Hybrid Intelligence (HI) as a synergistic paradigm, integrating human cognition with artificial intelligence via adaptive Brain-Computer Interfaces (BCI). It addresses the persistent “cognitive gap” in decision support by detailing the core components—human cognitive states and enabling technologies like EEG and fNIRS—and their integration into a closed-loop architecture. The discussion focuses on creating a “deep interpretation” engine for real-time cognitive state decoding, explores applications in critical domains, and examines the ethical and practical challenges of deploying such systems to augment human decision-making effectively.
- Open Access
- 3 June 2026
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 17 (2) , 248
Examining the Effects of Intermittent Theta Burst Stimulation on Accuracy and Reaction Time in N Back Tasks
Transcranial magnetic stimulation (TMS), especially intermittent theta burst stimulation (iTBS), has been extensively studied to improve brain function. Its ability to enhance cognitive functions, particularly working memory, has been widely investigated. This study aims to analyse the effects of a single session of iTBS applied to the left dorsolateral prefrontal cortex (DLPFC) on cognitive test performance, electroencephalography (EEG) correlates of working memory in healthy young subjects, and to assess accuracy and reaction time. A group of 14 healthy young adults aged between 19 and 23 years participated in the study. The subjects were arbitrarily distributed into two groups: with active (N=7) and sham (N=7) iTBS. The active 3-back test showed a positive impact on working memory performance with an increasing accuracy and with reduced average reaction time after 30 minutes of TMS session. It is concluded that iTBS over the DLPFC was responsible for enhancing working memory performance in healthy young adults, based on an observation that depicted improved accuracy and faster response times, especially within the Active 3 back test.
- 3 June 2026
- Published by Asociatia EduSoft in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
- Vol. 17 (2) , 248
Open AccessExamining the Effects of Intermittent Theta Burst Stimulation on Accuracy and Reaction Time in N Back Tasks
Transcranial magnetic stimulation (TMS), especially intermittent theta burst stimulation (iTBS), has been extensively studied to improve brain function. Its ability to enhance cognitive functions, particularly working memory, has been widely investigated. This study aims to analyse the effects of a single session of iTBS applied to the left dorsolateral prefrontal cortex (DLPFC) on cognitive test performance, electroencephalography (EEG) correlates of working memory in healthy young subjects, and to assess accuracy and reaction time. A group of 14 healthy young adults aged between 19 and 23 years participated in the study. The subjects were arbitrarily distributed into two groups: with active (N=7) and sham (N=7) iTBS. The active 3-back test showed a positive impact on working memory performance with an increasing accuracy and with reduced average reaction time after 30 minutes of TMS session. It is concluded that iTBS over the DLPFC was responsible for enhancing working memory performance in healthy young adults, based on an observation that depicted improved accuracy and faster response times, especially within the Active 3 back test.
- 20 March 2026
- Published by IGI Global Scientific Publishing
- p. 207-238
Transcranial Magnetic Stimulation as a Novel Therapeutic Strategy for Parkinson's Disease in Under-Resourced Settings
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized not only by motor deficits but also by cognitive impairment and network-level dysfunction. This chapter explores the therapeutic potential of Transcranial Magnetic Stimulation (TMS), a non-invasive neuromodulation technique. We posit that TMS can directly target maladaptive cortico-subcortical dynamics—such as pathological beta oscillations—and induce beneficial neuroplasticity, thereby addressing both motor and cognitive symptoms. The rationale for network-level intervention is supported by empirical data linking functional connectivity patterns, measured via EEG and source localization, to working memory performance. By reviewing physiological mechanisms, clinical protocols, and methodological integration, we argue that TMS represents a paradigm shift towards personalized, circuit-based remediation in PD, offering a promising adjunct to standard therapies for treatment-resistant symptoms.
- 20 March 2026
- Published by IGI Global Scientific Publishing
- p. 207-238
Transcranial Magnetic Stimulation as a Novel Therapeutic Strategy for Parkinson's Disease in Under-Resourced Settings
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized not only by motor deficits but also by cognitive impairment and network-level dysfunction. This chapter explores the therapeutic potential of Transcranial Magnetic Stimulation (TMS), a non-invasive neuromodulation technique. We posit that TMS can directly target maladaptive cortico-subcortical dynamics—such as pathological beta oscillations—and induce beneficial neuroplasticity, thereby addressing both motor and cognitive symptoms. The rationale for network-level intervention is supported by empirical data linking functional connectivity patterns, measured via EEG and source localization, to working memory performance. By reviewing physiological mechanisms, clinical protocols, and methodological integration, we argue that TMS represents a paradigm shift towards personalized, circuit-based remediation in PD, offering a promising adjunct to standard therapies for treatment-resistant symptoms.
- Open Access
- 25 November 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (23) , 2992
Modeling Working Memory in Neurodegeneration: A Focus on EEG Methods
Working memory is one of the most vulnerable cognitive domains in neurodegenerative diseases. According to the World Health Organization, around 55 million people worldwide were living with dementia in 2021, a number projected to exceed 150 million by 2050. Impairments in working memory occur in 80–90% of patients with Alzheimer’s disease, 40–60% with Parkinson’s disease, and about 50% with frontotemporal dementia. These deficits include reduced information capacity, slower response times, increased errors in manipulation, and difficulties in maintaining information, making them sensitive indicators of progressive decline. This review aims to systematize current approaches to modeling working memory phenotypes using electroencephalography (EEG). It highlights experimental paradigms applied to probe working memory, methods of EEG signal processing and analysis, and the integration of machine learning and neural network models. Particular emphasis is placed on studies achieving high diagnostic accuracy, with classification rates of 85–90% when distinguishing patients with neurodegeneration from healthy participants. Limitations of existing methods, especially EEG variability, are considered. The review concludes by outlining future directions: integration of multimodal EEG data, application of artificial intelligence, and development of digital cognitive biomarkers for hybrid models capable of predicting cognitive decline and advancing clinical translation.
- 25 November 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (23) , 2992
Open AccessModeling Working Memory in Neurodegeneration: A Focus on EEG Methods
Working memory is one of the most vulnerable cognitive domains in neurodegenerative diseases. According to the World Health Organization, around 55 million people worldwide were living with dementia in 2021, a number projected to exceed 150 million by 2050. Impairments in working memory occur in 80–90% of patients with Alzheimer’s disease, 40–60% with Parkinson’s disease, and about 50% with frontotemporal dementia. These deficits include reduced information capacity, slower response times, increased errors in manipulation, and difficulties in maintaining information, making them sensitive indicators of progressive decline. This review aims to systematize current approaches to modeling working memory phenotypes using electroencephalography (EEG). It highlights experimental paradigms applied to probe working memory, methods of EEG signal processing and analysis, and the integration of machine learning and neural network models. Particular emphasis is placed on studies achieving high diagnostic accuracy, with classification rates of 85–90% when distinguishing patients with neurodegeneration from healthy participants. Limitations of existing methods, especially EEG variability, are considered. The review concludes by outlining future directions: integration of multimodal EEG data, application of artificial intelligence, and development of digital cognitive biomarkers for hybrid models capable of predicting cognitive decline and advancing clinical translation.
- Open Access
- 13 August 2025
- Published by National Medical Research Center For Rehabilitation And Balneology in Bulletin of Rehabilitation Medicine
- Vol. 24 (4) , 156-167
Cognitive rehabilitation in multiple sclerosis: effectiveness and potential of virtual reality technologies. A review
Introduction. Innovative technologies in the rehabilitation of multiple sclerosis are aimed at introducing into clinical practice advanced methods and techniques for deep and comprehensive assessment and effective treatment of disorders not only in the motor, but also in the cognitive area. The aim of this review is to summarize and analyze current data on the potential of using virtual reality technologies in cognitive rehabilitation in multiple sclerosis. Aim. To summarise and analyse current evidence on the potential of using virtual reality technologies in cognitive rehabilitation in multiple sclerosis. Materials and methods. The search was conducted in PubMed, Scopus, RSCI databases using search queries and keywords in Russian and English: multiple sclerosis, cognitive, virtual reality/VR, immersive technologies, neurorehabilitation from 2014 to 2024. Main content of the review. Currently, in order to prevent the progression of cognitive deficit, 3D computer simulation technologies are being introduced, which provide realistic user interaction using special electronic equipment, visual and sound effects and multisensory feedback. Virtual reality systems demonstrate effectiveness in the rehabilitation of many diseases, allowing for the correction of impaired functions, stimulation of residual abilities and promotion of global health improvement. The restorative potential of virtual reality (VR) is realized through the complex involvement of the senses and stimulation of neuroplasticity, which develops specific cognitive and behavioral aspects of patient functioning. Increased feedback obtained through exercises performed in a virtual environment allows for the development of awareness of the results of the movements performed and the quality of the movements themselves, which has a positive effect on cognitive activity and motor control. The advantage of using VR technologies, especially with immersive tools, is to create a positive, motivating learning experience for the patient, which requires individual control over several sensorimotor and cognitive domains. Conclusion. This review analyzes the current scientific information in this area of research, provides a detailed assessment of the current state and potential of VR technologies in cognitive rehabilitation in multiple sclerosis, and discusses the fundamental mechanisms underlying neurorehabilitation using immersive technologies.
- 13 August 2025
- Published by National Medical Research Center For Rehabilitation And Balneology in Bulletin of Rehabilitation Medicine
- Vol. 24 (4) , 156-167
Open AccessCognitive rehabilitation in multiple sclerosis: effectiveness and potential of virtual reality technologies. A review
Introduction. Innovative technologies in the rehabilitation of multiple sclerosis are aimed at introducing into clinical practice advanced methods and techniques for deep and comprehensive assessment and effective treatment of disorders not only in the motor, but also in the cognitive area. The aim of this review is to summarize and analyze current data on the potential of using virtual reality technologies in cognitive rehabilitation in multiple sclerosis. Aim. To summarise and analyse current evidence on the potential of using virtual reality technologies in cognitive rehabilitation in multiple sclerosis. Materials and methods. The search was conducted in PubMed, Scopus, RSCI databases using search queries and keywords in Russian and English: multiple sclerosis, cognitive, virtual reality/VR, immersive technologies, neurorehabilitation from 2014 to 2024. Main content of the review. Currently, in order to prevent the progression of cognitive deficit, 3D computer simulation technologies are being introduced, which provide realistic user interaction using special electronic equipment, visual and sound effects and multisensory feedback. Virtual reality systems demonstrate effectiveness in the rehabilitation of many diseases, allowing for the correction of impaired functions, stimulation of residual abilities and promotion of global health improvement. The restorative potential of virtual reality (VR) is realized through the complex involvement of the senses and stimulation of neuroplasticity, which develops specific cognitive and behavioral aspects of patient functioning. Increased feedback obtained through exercises performed in a virtual environment allows for the development of awareness of the results of the movements performed and the quality of the movements themselves, which has a positive effect on cognitive activity and motor control. The advantage of using VR technologies, especially with immersive tools, is to create a positive, motivating learning experience for the patient, which requires individual control over several sensorimotor and cognitive domains. Conclusion. This review analyzes the current scientific information in this area of research, provides a detailed assessment of the current state and potential of VR technologies in cognitive rehabilitation in multiple sclerosis, and discusses the fundamental mechanisms underlying neurorehabilitation using immersive technologies.
- Open Access
- 30 July 2025
- Published by IntechOpen
Artificial Intelligence Algorithms in Neurology: Optimizing the Management of Patients with Multiple Sclerosis
Artificial intelligence (AI) and machine learning (ML) have revolutionized the field of neurology, particularly in the diagnosis and management of multiple sclerosis (MS). MS is a complex, immune-mediated neurological disorder characterized by demyelination and neurodegeneration, making early detection and continuous monitoring essential for effective treatment. Magnetic resonance imaging (MRI) is the gold standard for diagnosing MS, but traditional methods for lesion detection, segmentation, and disease progression assessment remain time-consuming and prone to variability. Recent advancements in AI-driven image analysis have significantly improved the accuracy and efficiency of MS diagnostics. Deep learning algorithms can automatically identify white matter lesions, quantify brain atrophy, and track disease progression with high precision. AI-powered models also enhance differential diagnosis by distinguishing MS from other demyelinating disorders, such as neuromyelitis optica spectrum disorder (NMOSD), through radiomics and multimodal data integration. Additionally, predictive AI algorithms analyzing MRI, cerebrospinal fluid biomarkers, and genetic data help forecast disease trajectories and treatment responses, enabling personalized therapeutic strategies. Despite these advancements, challenges remain in implementing AI for MS care, including data standardization, model interpretability, and ethical considerations related to bias and privacy. Explainable AI (XAI) and federated learning approaches are being explored to address these limitations and improve clinical adoption. The integration of AI with real-time patient monitoring tools, such as wearable sensors and digital biomarkers, holds promise for more comprehensive MS management. As AI continues to evolve, its role in neurology will expand, offering enhanced diagnostic accuracy, individualized treatment planning, and improved patient outcomes.
- 30 July 2025
- Published by IntechOpen
Open AccessArtificial Intelligence Algorithms in Neurology: Optimizing the Management of Patients with Multiple Sclerosis
Artificial intelligence (AI) and machine learning (ML) have revolutionized the field of neurology, particularly in the diagnosis and management of multiple sclerosis (MS). MS is a complex, immune-mediated neurological disorder characterized by demyelination and neurodegeneration, making early detection and continuous monitoring essential for effective treatment. Magnetic resonance imaging (MRI) is the gold standard for diagnosing MS, but traditional methods for lesion detection, segmentation, and disease progression assessment remain time-consuming and prone to variability. Recent advancements in AI-driven image analysis have significantly improved the accuracy and efficiency of MS diagnostics. Deep learning algorithms can automatically identify white matter lesions, quantify brain atrophy, and track disease progression with high precision. AI-powered models also enhance differential diagnosis by distinguishing MS from other demyelinating disorders, such as neuromyelitis optica spectrum disorder (NMOSD), through radiomics and multimodal data integration. Additionally, predictive AI algorithms analyzing MRI, cerebrospinal fluid biomarkers, and genetic data help forecast disease trajectories and treatment responses, enabling personalized therapeutic strategies. Despite these advancements, challenges remain in implementing AI for MS care, including data standardization, model interpretability, and ethical considerations related to bias and privacy. Explainable AI (XAI) and federated learning approaches are being explored to address these limitations and improve clinical adoption. The integration of AI with real-time patient monitoring tools, such as wearable sensors and digital biomarkers, holds promise for more comprehensive MS management. As AI continues to evolve, its role in neurology will expand, offering enhanced diagnostic accuracy, individualized treatment planning, and improved patient outcomes.
- 25 July 2025
- Published by IGI Global Scientific Publishing
- p. 153-184
Robotics and Neuroscience in Rehabilitation
This monograph explores the intersection of robotics and neuroscience in the field of motor neurorehabilitation, focusing on the development and application of brain-computer interface (BCI) systems. Emphasizing principles of neuroplasticity, it examines how technologies such as EEG-based BCI, functional electrical stimulation (FES), virtual reality (VR), and robotic exoskeletons can be integrated into closed-loop, feedback-rich rehabilitation platforms. Special attention is given to hybrid systems combining multiple sensory modalities to enhance user engagement and therapeutic outcomes. The monograph also discusses current challenges in clinical translation, including signal variability, training demands, and hardware limitations, while highlighting promising advances in AI-driven algorithms, wearable EEG solutions, and co-adaptive control strategies. Overall, it argues for a shift toward personalized, home-based rehabilitation technologies that empower patients with motor impairments to achieve greater autonomy and functional recovery.
- 25 July 2025
- Published by IGI Global Scientific Publishing
- p. 153-184
Robotics and Neuroscience in Rehabilitation
This monograph explores the intersection of robotics and neuroscience in the field of motor neurorehabilitation, focusing on the development and application of brain-computer interface (BCI) systems. Emphasizing principles of neuroplasticity, it examines how technologies such as EEG-based BCI, functional electrical stimulation (FES), virtual reality (VR), and robotic exoskeletons can be integrated into closed-loop, feedback-rich rehabilitation platforms. Special attention is given to hybrid systems combining multiple sensory modalities to enhance user engagement and therapeutic outcomes. The monograph also discusses current challenges in clinical translation, including signal variability, training demands, and hardware limitations, while highlighting promising advances in AI-driven algorithms, wearable EEG solutions, and co-adaptive control strategies. Overall, it argues for a shift toward personalized, home-based rehabilitation technologies that empower patients with motor impairments to achieve greater autonomy and functional recovery.